AMN vs. AMED, MD, CCRN, LH, DGX, DVA, CHE, CRVL, NSP, and ASGN
Should you be buying AMN Healthcare Services stock or one of its competitors? The main competitors of AMN Healthcare Services include Amedisys (AMED), Pediatrix Medical Group (MD), Cross Country Healthcare (CCRN), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Insperity (NSP), and ASGN (ASGN).
AMN Healthcare Services vs.
AMN Healthcare Services (NYSE:AMN) and Amedisys (NASDAQ:AMED) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, risk and media sentiment.
In the previous week, AMN Healthcare Services had 7 more articles in the media than Amedisys. MarketBeat recorded 9 mentions for AMN Healthcare Services and 2 mentions for Amedisys. Amedisys' average media sentiment score of 1.20 beat AMN Healthcare Services' score of 0.95 indicating that Amedisys is being referred to more favorably in the news media.
99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 94.4% of Amedisys shares are owned by institutional investors. 0.9% of AMN Healthcare Services shares are owned by insiders. Comparatively, 2.1% of Amedisys shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Amedisys has a net margin of 3.57% compared to AMN Healthcare Services' net margin of -4.93%. AMN Healthcare Services' return on equity of 15.22% beat Amedisys' return on equity.
AMN Healthcare Services currently has a consensus price target of $41.17, suggesting a potential upside of 76.53%. Amedisys has a consensus price target of $101.00, suggesting a potential upside of 8.63%. Given AMN Healthcare Services' stronger consensus rating and higher probable upside, equities research analysts clearly believe AMN Healthcare Services is more favorable than Amedisys.
AMN Healthcare Services has a beta of 0.15, indicating that its share price is 85% less volatile than the S&P 500. Comparatively, Amedisys has a beta of 0.76, indicating that its share price is 24% less volatile than the S&P 500.
Amedisys received 47 more outperform votes than AMN Healthcare Services when rated by MarketBeat users. However, 68.40% of users gave AMN Healthcare Services an outperform vote while only 58.58% of users gave Amedisys an outperform vote.
Amedisys has lower revenue, but higher earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks.
Summary
Amedisys beats AMN Healthcare Services on 10 of the 18 factors compared between the two stocks.
Get AMN Healthcare Services News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AMN Healthcare Services Competitors List
Related Companies and Tools
This page (NYSE:AMN) was last updated on 4/3/2025 by MarketBeat.com Staff
Buy AMN Stock Free AMN Stock Alerts